BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

17256

524075

ALBERTDAVD

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ALBERT DAVID LIMITED performance

Today’s low

Today’s high

₹ 842.05 ₹ 882.80
₹ 851.30

52 week low

52 week high

₹ 762.60 ₹ 1753.95
₹ 851.30

Open Price

₹ 882.80

Prev. Close

₹ 877.35

Volume (Shares)

6280.00

Total traded value

₹ 53.46

Upper Circuit

₹ 1052.80

Lower Circuit

₹ 701.90

info

ALBERT DAVID LIMITED Share Price Update

As of the latest trading session, ALBERT DAVID LIMITED share price is currently at ₹ 844.45, which is down by ₹ -32.89 from its previous closing. Today, the stock has fluctuated between ₹ 842.05 and ₹ 882.80. Over the past year, ALBERT DAVID LIMITED has achieved a return of -26.50 %. In the last month alone, the return has been -0.24 %. Read More...

ALBERT DAVID LIMITED fundamentals


  • Market cap (Cr)

    486.10

  • P/E Ratio (TTM)

    12.42

  • Beta

    1.11

  • Book Value / share

    723.70

  • Return on equity

    21.72%

  • EPS (TTM)

    70.83

  • Dividend yield

    1.31%

  • Net profit/quarter (Cr)

    -9.39

info icon alternate text
  • Market cap (Cr)

    485.00

  • P/E Ratio (TTM)

    12.42

  • Beta

    1.07

  • Book Value / share

    723.70

  • Return on equity

    21.72%

  • EPS (TTM)

    70.83

  • Dividend yield

    1.31%

  • Net profit/quarter (Cr)

    -9.39

info icon alternate text

ALBERT DAVID LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 83.08
Operating Expense 84.24
Net Profit -9.39
Net Profit Margin (%) -11.30
Earnings Per Share (EPS) -16.45
EBITDA -8.33
Effective Tax Rate (%) 7.57
Particulars SEP 2024 (Values in Cr)
Revenue 98.44
Operating Expense 93.94
Net Profit 18.07
Net Profit Margin (%) 18.35
Earnings Per Share (EPS) 31.67
EBITDA 26.86
Effective Tax Rate (%) 28.09
Particulars JUN 2024 (Values in Cr)
Revenue 89.36
Operating Expense 90.35
Net Profit 18.84
Net Profit Margin (%) 21.08
Earnings Per Share (EPS) 33.02
EBITDA 23.93
Effective Tax Rate (%) 14.59
Particulars MAR 2024 (Values in Cr)
Revenue 89.06
Operating Expense 81.38
Net Profit 12.91
Net Profit Margin (%) 14.49
Earnings Per Share (EPS) 22.63
EBITDA 20.00
Effective Tax Rate (%) 28.71
Particulars DEC 2023 (Values in Cr)
Revenue 88.28
Operating Expense 81.73
Net Profit 18.72
Net Profit Margin (%) 21.20
Earnings Per Share (EPS) 32.80
EBITDA 25.24
Effective Tax Rate (%) 20.13
Particulars MAR 2024 (Values in Cr)
Revenue 362.46
Operating Expense 322.73
Net Profit 75.42
Net Profit Margin (%) 20.80
Earnings Per Share (EPS) 132.15
EBITDA 104.44
Effective Tax Rate (%) 22.47
Particulars MAR 2023 (Values in Cr)
Revenue 341.56
Operating Expense 306.22
Net Profit 36.17
Net Profit Margin (%) 10.58
Earnings Per Share (EPS) 63.39
EBITDA 59.75
Effective Tax Rate (%) 28.69
Particulars MAR 2022 (Values in Cr)
Revenue 313.51
Operating Expense 282.04
Net Profit 35.26
Net Profit Margin (%) 11.24
Earnings Per Share (EPS) 61.78
EBITDA 56.64
Effective Tax Rate (%) 25.45
Particulars MAR 2021 (Values in Cr)
Revenue 247.45
Operating Expense 237.18
Net Profit 22.14
Net Profit Margin (%) 8.94
Earnings Per Share (EPS) 38.80
EBITDA 36.32
Effective Tax Rate (%) 19.31
Particulars MAR 2020 (Values in Cr)
Revenue 320.80
Operating Expense 298.96
Net Profit 19.17
Net Profit Margin (%) 5.97
Earnings Per Share (EPS) 33.59
EBITDA 37.42
Effective Tax Rate (%) 33.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 671.05
ROE % 21.72
ROCE % 26.86
Total Debt to Total Equity 0.01
EBITDA Margin 28.84
Particulars MAR 2023 (Values in Cr)
Book Value / Share 545.93
ROE % 12.24
ROCE % 16.36
Total Debt to Total Equity 0.02
EBITDA Margin 17.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 489.68
ROE % 13.46
ROCE % 17.16
Total Debt to Total Equity 0.01
EBITDA Margin 18.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 428.20
ROE % 9.48
ROCE % 11.27
Total Debt to Total Equity 0.01
EBITDA Margin 14.73
Particulars MAR 2020 (Values in Cr)
Book Value / Share 390.38
ROE % 8.85
ROCE % 12.86
Total Debt to Total Equity 0.01
EBITDA Margin 11.72
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 31.16
Total Assets 497.99
Total Liabilities 497.99
Total Equity 382.98
Share Outstanding 5707162
Price to Book Ratio 1.60
Return on Assets (%) 15.14
Return on Capital (%) 19.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 25.22
Total Assets 423.39
Total Liabilities 423.39
Total Equity 311.57
Share Outstanding 5707162
Price to Book Ratio 0.94
Return on Assets (%) 8.54
Return on Capital (%) 11.46
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 18.56
Total Assets 401.23
Total Liabilities 401.23
Total Equity 279.47
Share Outstanding 5707162
Price to Book Ratio 1.09
Return on Assets (%) 8.78
Return on Capital (%) 12.45
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 35.36
Total Assets 341.38
Total Liabilities 341.38
Total Equity 244.38
Share Outstanding 5707162
Price to Book Ratio 0.88
Return on Assets (%) 6.48
Return on Capital (%) 9.04
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.74
Total Assets 320.21
Total Liabilities 320.21
Total Equity 222.79
Share Outstanding 5707162
Price to Book Ratio 0.82
Return on Assets (%) 5.98
Return on Capital (%) 8.55
Particulars MAR 2024 (Values in Cr)
Net Income 97.28
Cash from Operations 61.61
Cash from Investing -33.24
Cash from Financing -8.26
Net change in Cash 3.98
Free Cash Flow 72.48
Particulars MAR 2023 (Values in Cr)
Net Income 50.73
Cash from Operations 26.22
Cash from Investing -4.99
Cash from Financing -6.36
Net change in Cash -0.84
Free Cash Flow 31.45
Particulars MAR 2022 (Values in Cr)
Net Income 47.29
Cash from Operations 52.98
Cash from Investing -39.69
Cash from Financing -1.59
Net change in Cash -0.87
Free Cash Flow 64.06
Particulars MAR 2021 (Values in Cr)
Net Income 27.44
Cash from Operations 38.91
Cash from Investing -38.68
Cash from Financing -1.70
Net change in Cash -3.77
Free Cash Flow 40.54
Particulars MAR 2020 (Values in Cr)
Net Income 28.95
Cash from Operations 45.44
Cash from Investing -19.99
Cash from Financing -10.32
Net change in Cash -0.07
Free Cash Flow 60.87
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 39.43 21.20 2.15 302.17 34.11 / 77.70
BLISS GVS PHARMA LTD 126.30 16.55 1.31 1330.83 92.25 / 184.95
CIPLA LTD 1551.30 25.11 4.41 125285.64 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 289.65 24.00 2.93 852.47 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2916.75 57.85 29.54 49411.50 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 39.43 23.75 6.70 302.17 34.11 / 77.70
AMRUTAJAN HEALTH LTD 672.50 39.42 6.52 1944.24 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8961.95 133.66 32.97 22404.88 5000.00 / 9199.00
BLISS GVS PHARMA LTD 126.30 16.40 1.29 1330.83 92.25 / 184.95

ALBERT DAVID LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
851.30 -2.96 redarrow
red-green-graph indicator
10 Bearish
6 Bullish
  • 5 Days 866.30
  • 26 Days 854.90
  • 10 Days 853.40
  • 50 Days 910.00
  • 12 Days 850.60
  • 100 Days 1025.50
  • 20 Days 848.70
  • 200 Days 1113.70
873.78 PIVOT

First Support

861.42

First Resistance

884.57

Second Support

850.63

Second Resistance

896.93

Third Support

838.27

Third Resistance

907.72

RSI

54.55

ADX

14.60

MACD

-4.33

Williams % R

-12.67

Commodity Channel Index (CCI)

92.89

Date

2025-04-24

Week

3432.00

Same Day

4601.00

Month

5429.00

1 Year

1.11

3 Year

0.94

Over 1 Month

-0.24%

down

Over 1 Year

-26.50%

down

Over 3 Months

-28.85%

down

Over 3 Years

14.67%

down

Over 6 Months

-36.12%

down

Over 5 Years

12.20%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

ALBERT DAVID LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
35.1%
Promoter Holdings
62.23%
FII
1.0%
DII
1.64%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Kothari Investment And Industries Private Limited 2360531.0 (41.36%) Shareholding of Promoter and Promoter Group
Anand Vardhan Kothari 566500.0 (9.93%) Shareholding of Promoter and Promoter Group
M D Kothari And Company Limited 394700.0 (6.92%) Shareholding of Promoter and Promoter Group
Kothari Phytochemicals & Industries Limited 99200.0 (1.74%) Shareholding of Promoter and Promoter Group
Arun Kumar Kothari 97000.0 (1.7%) Shareholding of Promoter and Promoter Group
General Insurance Corporation Of India 91850.0 (1.61%) Public Shareholding
Biyani Financial Services Pvt.ltd. 57250.0 (1.0%) Public Shareholding
Prabhawati Devi Kothari 17527.0 (0.31%) Shareholding of Promoter and Promoter Group
Paramsukhdas Suganchand Huf (karta - Arun Kumar Kothari) 15000.0 (0.26%) Shareholding of Promoter and Promoter Group
Vedika Kothari 1500.0 (0.03%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ALBERT DAVID LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
03 Aug 2023 9.0 Final 03 Aug 2023 Equity shares
01 Aug 2022 9.0 Final 02 Aug 2022 Equity shares
06 Sep 2021 6.0 Final 07 Sep 2021 Equity shares
13 Mar 2020 7.0 Interim 16 Mar 2020 Equity shares
01 Aug 2019 6.0 Final 03 Aug 2019 Equity shares
24 Aug 2018 5.5 Final 28 Aug 2018 Equity shares
01 Sep 2017 5.5 Final 05 Sep 2017 Equity shares
21 Mar 2016 5.5 Interim 22 Mar 2016 Equity shares
21 Aug 2015 5.5 Final 25 Aug 2015 Equity shares
01 Aug 2014 5.0 Final 05 Aug 2014 Equity shares
31 Jul 2013 4.5 Final 02 Aug 2013 Equity shares
03 Aug 2012 4.5 Final 07 Aug 2012 Equity shares
29 Jul 2011 4.5 Final 02 Aug 2011 Equity shares
25 Jun 2010 4.5 Final 29 Jun 2010 Equity shares
29 Jun 2009 3.5 Final 01 Jul 2009 Equity shares
23 Jul 2008 3.0 Final 25 Jul 2008 Equity shares
13 Jul 2007 3.0 Final 17 Jul 2007 Equity shares
06 Jul 2005 0.0 Final 08 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
03 Aug 2023 9.0 Final 03 Aug 2023 Equity shares
01 Aug 2022 9.0 Final 02 Aug 2022 Equity shares
06 Sep 2021 6.0 Final 07 Sep 2021 Equity shares
13 Mar 2020 7.0 Interim 16 Mar 2020 Equity shares
01 Aug 2019 6.0 Final 03 Aug 2019 Equity shares
24 Aug 2018 5.5 Final 28 Aug 2018 Equity shares
01 Sep 2017 5.5 Final 05 Sep 2017 Equity shares
21 Mar 2016 5.5 Interim 22 Mar 2016 Equity shares
21 Aug 2015 5.5 Final 25 Aug 2015 Equity shares
01 Aug 2014 5.0 Final 05 Aug 2014 Equity shares
31 Jul 2013 4.5 Final 02 Aug 2013 Equity shares
03 Aug 2012 4.5 Final 07 Aug 2012 Equity shares
29 Jul 2011 4.5 Final 02 Aug 2011 Equity shares
25 Jun 2010 4.5 Final 29 Jun 2010 Equity shares
29 Jun 2009 3.5 Final 01 Jul 2009 Equity shares
23 Jul 2008 3.0 Final 25 Jul 2008 Equity shares
13 Jul 2007 3.0 Final 17 Jul 2007 Equity shares
06 Jul 2005 0.0 Final 08 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ALBERT DAVID LIMITED Share Price

Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the 'Kothari Group'. The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers.

ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.'90 augmented the long-term working capital.

ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.

During 1998-99, the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company has launched new products-INTECAR,NIMERIL-T,EVICT,ALROF-50. It is also planning to launch new products such as SIOOXY,ALAMIN FEZ,PANSURE.

New products were launched such as - INTECAR Capsules, NIMERIL-T, EVICT, ALROF-50, ADLIN and SLOZIN during the year 2003; new products such as Alamin-FeZ and Pansure were introduced in 2004. SIOOXY (Anti-Oxidant with OMEGA-3 Fatty Acid) was launched in 2005, launched ALAMTN-Xtra, VERBET - the antivertigo drug and water for injection during year 2006; launched Antibiotic Azithromycin under brand 'AZ3' and expanded its Vision Care range (launched Antiglaucoma products, Antiinfectives, Irrigating Solution and Steroidal combinations) in 2009; launched uterine tonic-Siocare and Laxative combination-Evict Fibre and has also expanded its Anti-inflammatory & Analgesic range with launch of Anaflam XP in 2010; launched Rabeprazole and its combination (Anti-Peptic Ulcerant range) and Montelukast and its combination (Anti Asthmatic range) in 2013; launched Alamin Liquid and Alamin RLD (L-Arginine Sachet) in 2014; launched Dhup Tab & Drop (Vit.D3), Inbalanse-Z (probiotic) and Evict-XF (Laxative) in 2015; launched Sioneuron M/PG capsules, Inbalanse-Z capsules and Breaze-Fx tablet in 2017. It introduced two products i.e., Evacure and C3H in the market during year 2021-22.

Parent organization Indian Private
NSE symbol ALBERTDAVD
Founded 1938
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Albert David Ltd?

Answer Field

The share price of Albert David Ltd for NSE is ₹ 844.45 and for BSE is ₹ 849.8.

What is the Market Cap of Albert David Ltd?

Answer Field

The market cap of Albert David Ltd for NSE is ₹ 4,86.10 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Albert David Ltd?

Answer Field

The 52 Week High and Low of Albert David Ltd for NSE is ₹ 1753.95 and ₹ 762.60 and for BSE is ₹ 1752.95 and ₹ 763.90.

How to Buy Albert David Ltd share?

Answer Field

You can trade in Albert David Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Albert David Ltd?

Answer Field

The 1 year returns on the stock has been -26.50%.

What is the Current Share Price of Albert David Ltd?

Answer Field

Albert David Ltd share price is for NSE ₹ 844.45 & for BSE ₹ 849.8 as on Apr 25 2025 03:29 PM.

What is the Market Cap of Albert David Ltd Share?

Answer Field

The market cap of Albert David Ltd for NSE ₹ 4,86.10 & for BSE ₹ 0.0 as on Apr 25 2025 03:29 PM.

What is the P/E Ratio of Albert David Ltd Share?

Answer Field

As on Apr 25 2025 03:29 PM the price-to-earnings (PE) ratio for Albert David Ltd share is 12.42.

What is the PB ratio of Albert David Ltd Share?

Answer Field

As on Apr 25 2025 03:29 PM, the price-to-book (PB) ratio for Albert David Ltd share is 723.70.

How to Buy Albert David Ltd Share?

Answer Field

You can trade in Albert David Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Albert David Ltd Share on Bajaj Broking App?

Answer Field

To buy Albert David Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Albert David Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|